OMI earnings

Signed Definitive Agreement for the Sale of Products & Healthcare Services Segment Transaction Positions the Company as a Pure-Play Home-Based Care Business Owens & Minor, Inc. (NYSE:OMI) today reported financial results for the third quarter ended September 30, 2025. Unless otherwise noted, the results herein reflect the Company's continuing operations, which primarily represent what was previously the Patient Direct segment and certain functional operations. "Our recent announcement on the sale of our Products & Healthcare Services segment is another meaningful step in our strategy to pivot our focus to the more attractive home-based care space. We are keenly focused on reshaping ou

Owens & Minor, Inc. (NYSE:OMI) plans to release financial results for the third quarter of 2025 on Thursday, October 30, 2025, after trading ends on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 5:00 p.m. EDT on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All interested stakeholders are encouraged to access the simultaneous live webcast by visiting the Investor Relations page of the Owens & Minor website available at investors.owens-minor.com/events-and-presentations/. A replay of the webcast c

Transforms Owens & Minor into a Pure Play Market Leader in the Home-Based Care Market 5% Retained Equity Stake Provides Ability to Realize Future Value Creation Under Platinum Equity Preserves Tax Attributes in Excess of $150 Million Owens & Minor, Inc. (NYSE:OMI) today announced that it has entered into a definitive agreement for the sale of the Company's Products & Healthcare Services (P&HS) segment to Platinum Equity. Over the last several years, Owens & Minor has been strategically moving towards expanding its leadership position in the very attractive home-based care space. This transaction will allow the Company to focus on a simpler business model and allow for a more appropria

Classified Products & Healthcare Services Segment as Discontinued Operations Continuing Operations, Patient Direct, Showed Solid Performance and Growth Owens & Minor, Inc. (NYSE:OMI) today reported financial results for the second quarter ended June 30, 2025. In connection with a likely sale of the Company's Products & Healthcare Services segment, the results herein, unless otherwise noted, reflect the Company's continuing operations which primarily represent what was previously the Patient Direct segment and certain functional operations. "We are in the final stages of our robust process for the divestiture of the Products & Healthcare Services segment, and, as a result, have classif

Owens & Minor, Inc. (NYSE:OMI) plans to release financial results for the second quarter of 2025 on Monday, August 11, 2025, before trading begins on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 8:30 a.m. EDT on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All interested stakeholders are encouraged to access the simultaneous live webcast by visiting the Investor Relations page of the Owens & Minor website available at investors.owens-minor.com/events-and-presentations/. A replay of the webcast

Top-Line Growth Led by the Patient Direct Segment Patient Direct Operating Margin Expanded by 173 Basis Points Company Reaffirmed 2025 Financial Guidance Remain Actively Engaged in Potential Sale of Products & Healthcare Services Segment Owens & Minor, Inc. (NYSE:OMI) today reported financial results for the first quarter ended March 31, 2025. "Across the business we continued to see strong execution and progress towards our near and long-term strategies. Patient Direct delivered mid-single digit top-line growth with strong performance in nearly all therapy categories led by Diabetes and Sleep Supplies. The top-line growth combined with strong operational execution delivered mid-teen e

Owens & Minor, Inc. (NYSE:OMI) plans to release financial results for the first quarter of 2025 on Thursday, May 8, 2025, before trading begins on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 8:00 a.m. EDT on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All interested stakeholders are encouraged to access the simultaneous live webcast by visiting the Investor Relations page of the Owens & Minor website available at investors.owens-minor.com/events-and-presentations/. A replay of the webcast can b

Total Debt Reduction of $244 Million in 2024, Capping a Two-Year Total Debt Reduction of $647 Million 2025 Guidance Midpoint Indicates Double-Digit Adjusted EBITDA & Adjusted EPS Growth, and Improving Cash Flow Active Discussions Well Underway Regarding Potential Sale of Products & Healthcare Services (P&HS) Segment Board of Directors Authorizes Share Repurchase Program of Up to $100 Million Owens & Minor, Inc. (NYSE:OMI) today reported financial results for the fourth quarter and year ended December 31, 2024. "We are pleased with the progress that we have made against the strategy as outlined at our Investor Day in December 2023. As a reminder, we committed to optimizing our Prod

Expects to Report Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025 Owens & Minor, Inc. (NYSE:OMI) (the "Company") today announced selected preliminary financial results for the fourth quarter and year ended December 31, 2024 in advance of its upcoming earnings announcement and conference call. The release of the preliminary results relates to the Company's commencement of financing activity related to its previously announced agreement to acquire Rotech Healthcare Holdings, Inc ("Rotech"). "We are commencing a process to raise additional debt while the capital markets are attractive, to finance our previously announced agreement to acquire Rotech which we continu

Top-Line Growth Driven by Continued Solid Demand in Patient Direct and Medical Distribution Total Debt Reduction of Nearly $200 Million in the Third Quarter Owens & Minor, Inc. (NYSE:OMI) today reported financial results for the third quarter ended September 30, 2024. Key Highlights: Consolidated revenue of $2.7 billion in the third quarter, representing year-over-year growth of 5% GAAP Net loss of $(13) million or $(0.17) per share, and adjusted earnings per share of $0.42 in the third quarter Adjusted EBITDA of $142 million in the third quarter, representing year-over-year growth of 5% $198 million in total debt reduction in the third quarter "Our third quarter results demons

Owens & Minor, Inc. (NYSE:OMI) plans to release financial results for the third quarter of 2024 on Monday, November 4, 2024, before trading begins on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 8:30 a.m. ET on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All interested stakeholders are encouraged to access the simultaneous live webcast by visiting the Investor Relations page of the Owens & Minor website available at investors.owens-minor.com/events-and-presentations/. A replay of the webcast can

Top Line Expansion Driven by Solid Growth in Both Segments Second Quarter Operating Cash Flow of $116 Million Drove $71 million in Debt Reduction Expanding Patient Direct Segment with Agreement to Acquire Rotech Healthcare Holdings Owens & Minor, Inc. (NYSE:OMI) today reported financial results for the second quarter ended June 30, 2024. Key Highlights: Consolidated revenue of $2.7 billion in the second quarter, representing year-over-year growth of 4% Net loss of $(32) million or $(0.42) per share in the second quarter Adjusted EBITDA of $127 million in the second quarter, representing year-over-year growth of 12% Doubled second quarter year over year Adjusted earnings

Plans to Release Full Results on Friday, August 2 Before the NYSE Open Owens & Minor, Inc. (NYSE:OMI) today announced selected preliminary financial results for the quarter ended June 30, 2024 as noted in the table below. The Company also reaffirmed its outlook for the full year 2024 as noted below in advance of its second quarter 2024 earnings announcement and conference call. Selected Preliminary Financial Results for the Quarter Ended June 30, 2024 (1)   ($ in millions, except per share data)   2Q24     Revenue $2,651 - $2,671     Operating income, GAAP $16 - $20 Adj. Operating Income, Non-GAAP

Strategy Articulated at Investor Day is Advanced by Strengthening Our Patient Direct Segment's Position as a Premier Growth Platform in Home-Based Care Combined Capabilities Support Improved Service to Patients, Providers, and Payors Adjusted EPS Neutral in First Full Year and Approximately $0.15 Accretion in Second Year Company Reports Preliminary Second Quarter Results and Reaffirms 2024 Full Year Guidance in Separate Press Release Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI), today announced that it has entered into a definitive agreement to acquire Rotech Healthcare Holdings, Inc. ("Rotech"), a privately held home based care business headquartered in Orlando, Florida, for $1

Gross Margin Expansion of 79 Basis Points Adjusted EPS Growth of Nearly Four Times with GAAP EPS Loss of $(0.29) and Adjusted EPS of $0.19 Investments Outlined at 2023 Investor Day for Long-Term Growth are Ahead of Plan Owens & Minor, Inc. (NYSE:OMI) today reported financial results for the first quarter ended March 31, 2024. Key Highlights: Consolidated revenue of $2.6 billion in the first quarter, representing year-over-year growth of 4% GAAP operating margin was flat while adjusted operating margin expanded by 31 basis points versus prior year Net loss per share of $(0.29) and adjusted earnings per share of $0.19 in the first quarter "Our solid performance in the firs

Owens & Minor, Inc. (NYSE:OMI) plans to release financial results for the first quarter of 2024 on Friday, May 3, 2024, before trading begins on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 8:30 a.m. ET on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All interested stakeholders are encouraged to access the simultaneous live webcast by visiting the investor relations page of the Owens & Minor website available at investors.owens-minor.com/events-and-presentations/. A replay of the webcast can be

Business Delivered Strong Operating Margin Improvement in Fourth Quarter Robust Full Year Operating Cash Flow Generation Enabled Significant Debt Reduction Owens & Minor, Inc. (NYSE:OMI) today reported financial results for the fourth quarter and year ended December 31, 2023. Full Year 2023 Key Highlights: Consolidated revenue of $10.3 billion Delivered $741 million of operating cash flow Reduced total debt by $403 million and reduced net debt by $577 million Net loss per common share of $(0.54) and adjusted net income per common share of $1.36 "We once again delivered on our commitments and had a strong finish to 2023, demonstrated by our top-line growth across both bu

Owens & Minor, Inc. (NYSE:OMI) plans to release financial results for the fourth quarter of 2023 on Tuesday, February 20, 2024, before trading begins on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 8:30 a.m. ET on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All interested stakeholders are encouraged to access the simultaneous live webcast by visiting the investor relations page of the Owens & Minor website available at investors.owens-minor.com/events-and-presentations/. A replay of the webcas

Top Line Expansion Led by Healthy Demand in Patient Direct and Medical Distribution Operating Cash Flow Generation Supported $188 million in Total Debt Reduction Owens & Minor, Inc. (NYSE:OMI) today reported financial results for the third quarter ended September 30, 2023. Third Quarter Key Highlights: Consolidated revenue of $2.59 billion Net loss per common share of $(0.08) and adjusted net income per common share of $0.44 $188 million in total debt pay down and $117 million reduction in net debt "Our performance in the third quarter is another strong indication that our business strategy and execution are working, and that we are beginning to realize the benefits of the

Owens & Minor, Inc. (NYSE:OMI) plans to release financial results for the third quarter of 2023 on Friday, November 3, 2023, before trading begins on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 8:00 a.m. ET on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All interested stakeholders are encouraged to access the simultaneous live webcast by visiting the investor relations page of the Owens & Minor website available at investors.owens-minor.com/events-and-presentations/. A replay of the webcast c

Owens & Minor, Inc. (NYSE:OMI) plans to release financial results for the third quarter of 2023 on Friday, November 3, 2023, before trading begins on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 8:30 a.m. ET on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All interested stakeholders are encouraged to access the simultaneous live webcast by visiting the investor relations page of the Owens & Minor website available at investors.owens-minor.com/events-and-presentations/. A replay of the webcast c

Top-line Growth Driven by Strong Performance in Patient Direct Operating Model Realignment Program Remains on Track Operating Cash Flow of $313 Million, Inclusive of $115 Million in Receivables Sales Owens & Minor, Inc. (NYSE:OMI) today reported financial results for the second quarter ended June 30, 2023. Second Quarter Key Highlights: Consolidated revenue of $2.56 billion Net loss per common share of $(0.37) and adjusted net income per common share of $0.18 $49.3 million in debt pay down and $269 million reduction in net debt "The second quarter of 2023 shows a continuation of our Patient Direct segment's exceptional performance, with another quarter of double-digit gr

Owens & Minor, Inc. (NYSE:OMI) plans to release financial results for the second quarter of 2023 on Friday, August 4, 2023, before trading begins on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 8:30 a.m. ET on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All interested stakeholders are encouraged to access the simultaneous live webcast by visiting the investor relations page of the Owens & Minor website available at investors.owens-minor.com/events-and-presentations/. A replay of the webcast ca

Strength of Patient Direct Drove Gross Margin Expansion Operating Model Realignment Program Remains on Track Raised Midpoint of 2023 Guidance Based on Strong Patient Direct Performance and Profit Improvement Efforts Owens & Minor, Inc. (NYSE:OMI) today reported financial results for the first quarter ended March 31, 2023. Key Highlights: Consolidated revenue of $2.5 billion in the first quarter Net loss per common share of $(0.32) and adjusted net income per common share of $0.05 in the first quarter $158 million of operating cash flow generated in the first quarter $117 million in debt pay down 2023 outlook reflects strong financial performance in the Patient Direct

Management will host a conference call to discuss results on Friday, May 5 at 8:30 a.m. ET Owens & Minor, Inc. (NYSE:OMI) plans to release financial results for the first quarter of 2023 on Friday, May 5, 2023, before trading begins on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 8:30 a.m. ET on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All interested stakeholders are encouraged to access the simultaneous live webcast by visiting the investor relations page of the Owens & Minor website ava

Management will host a conference call to discuss results on Tuesday, February 28 at 8:00 a.m. ET Owens & Minor, Inc. (NYSE:OMI) plans to release financial results for the fourth quarter and full year of 2022 on Tuesday, February 28, 2023, before trading begins on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 8:00 a.m. ET on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All interested stakeholders are encouraged to access the simultaneous live webcast by visiting the investor relations page of the

Adjusted EBITDA of $127 million, margin up 140 basis points Patient Direct Revenue Growth of 142%, or 11.4% on a Pro Forma Basis for the Apria Acquisition Generated $69 million of cash from operations in the quarter Owens & Minor, Inc. (NYSE-OMI) today reported financial results for the third quarter ended September 30, 2022, as summarized in the table below. "In the third quarter we saw greater than expected macro-economic and industry-related forces that continue to challenge our Products & Healthcare Services segment and as the quarter progressed, we saw more of our acute care customers delay reorders utilizing their stockpiled items," said Edward A. Pesicka, President & Chief Executiv

Company also Provides Preliminary Results for the 3rd Quarter and Updated Guidance for 2022 Owens & Minor, Inc. (NYSE-OMI) today announced certain changes to its executive leadership team, including the appointment of Andrew G. Long as EVP, CEO, Products & Healthcare Services segment, replacing Jeffrey T. Jochims who will be leaving the Company. Long has served as the Company's EVP and CFO since joining the Company in November 2019. In addition, Alexander J. Bruni has been promoted to EVP and CFO, replacing Long. "Andy has been a great leader at Owens & Minor and I am looking forward to having Andy in this role where his skillset will help drive the Products & Healthcare Services segment

Continued strength in Patient Direct with strong organic growth and acquisition synergies on track Delivered Q2 adjusted EBITDA of $156 million Weaker economic conditions and hospital volumes lead to new FY22 Adj. EPS outlook of $2.85-$3.15 Owens & Minor, Inc. (NYSE-OMI) today reported financial results for the second quarter ended June 30, 2022, as summarized in the table below. "I am very pleased with our performance in the second quarter, where the strength of our business model and the O&M business system helped us in the face of external conditions that continued to deteriorate over the quarter," said Edward A. Pesicka, President and Chief Executive Officer. "Our Patient Direct segm

Management will host a conference call to discuss results at 8:00 a.m. ET on August 3rd Owens & Minor, Inc. (NYSE:OMI) plans to release financial results for the second quarter of 2022 before market open on Wednesday, August 3, 2022. The Company will host a conference call and simultaneous webcast for investors at 8:00 a.m. ET on the same day to review its financial results. The live webcast will be available on Owens & Minor's Investor Relations website in the Events & Presentations section. Conference call participants are required to register in advance to obtain call-in information prior to the start of the call. About Owens & Minor Owens & Minor, Inc. (NYSE:OMI) is a Fortune 500 gl

Continued revenue growth in both segments, highlighted by 26% growth in Patient Direct Q1 GAAP EPS of $0.52, Adjusted EPS of $0.96 2022 Adjusted EPS outlook revised upward to a range of $3.05 - $3.55 Owens & Minor, Inc. (NYSE-OMI) today reported financial results for the first quarter ended March 31, 2022, as summarized in the table below. "The first quarter of 2022 marked an important milestone - we completed the largest acquisition in the Company's history. With the acquisition of Apria, we have strengthened our position in the higher-growth direct-to-patient home market, enhancing our ability to serve patients through the hospital and into the home. I am excited to welcome the Apria

Management will host a conference call to discuss results at 4:30 p.m. ET on May 3rd Owens & Minor, Inc. (NYSE:OMI) plans to release financial results for the first quarter of 2022 after market close on Tuesday, May 3, 2022. The Company will host a conference call for investors at 4:30 p.m. ET to review its financial results. Participants may access the call at 866-393-1604. The international dial-in number is 1-224-357-2191. A replay of the call will be available for one week by dialing 855-859-2056. The access code for the conference call, international dial-in and replay is 7829537. A webcast of the event will be available on www.owens-minor.com under the Investor Relations section. A

Strong Finish to a Year with Robust Growth and Record Setting Profitability Company Reaffirms 2022 Guidance Acquisition of Apria Remains on Track Owens & Minor, Inc. (NYSE-OMI) today reported financial results for the fourth quarter and the year ended December 31, 2021, as summarized in the table below. "I'm extremely proud of our strong finish to a record year and even more excited about our future. We delivered on our commitments to all stakeholders and took major steps to help ensure the future growth of Owens & Minor," said Edward A. Pesicka, President & Chief Executive Officer. Pesicka added, "In an ever-changing healthcare environment it is the strength of our business model that r

Management will host a conference call to discuss results at 8:30 a.m. ET on February 23rd Owens & Minor, Inc. (NYSE:OMI) plans to release financial results for the fourth quarter and full year of 2021 on Wednesday, February 23, 2022, before trading begins on the New York Stock Exchange. Later that same morning, the Company will host a conference call at 8:30 a.m. EDT to discuss the results. Participants may access the call at 866-393-1604. The international dial-in number is 1-224-357-2191. A replay of the call will be available for one week by dialing 855-859-2056. The access code for the conference call, international dial-in and replay is 2388913. A webcast of the event will be availa

Highly Complementary Transaction Expands Patient Direct Offering Year-One Accretion Across Key Financial Metrics and Free Cash Flow Enhancement Creates a Leading Platform for Future Growth Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) and Apria, Inc. ("Apria") (NASDAQ:APR) today announced that the companies have entered into a definitive agreement pursuant to which Owens & Minor will acquire Apria for $37.50 in cash per share of common stock, representing an equity value of approximately $1.45 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220110005291/en/ "I'm very excited about the acquisition of Apria, which wil

Year-over-Year Revenue Growth of over 14% Continued Expansion of Operating Margin in Global Solutions Narrows Range for 2021 guidance and Affirms previously announced 2022 guidance Owens & Minor, Inc. (NYSE-OMI) today reported financial results for the third quarter of 2021, as summarized in the table below. "I'm pleased that in the third quarter, we continued on our path to a record setting year. Our performance reflects the results of consistently providing high quality service and value to our customers while strengthening the financial position of the company," said Edward A. Pesicka, President & Chief Executive Officer of Owens & Minor. Pesicka added, "We saw continued top and bot

Management will host a conference call to discuss results at 8:30 a.m. EDT on November 3rd Owens & Minor, Inc. (NYSE:OMI) plans to release financial results for the third quarter of 2021 on Wednesday, November 3, 2021, before trading begins on the New York Stock Exchange. Later that same morning, the Company will host a conference call at 8:30 a.m. EDT to discuss the results. Participants may access the call at 866-393-1604. The international dial-in number is 1-224-357-2191. A replay of the call will be available for one week by dialing 855-859-2056. The access code for the conference call, international dial-in and replay is 1735879. A webcast of the event will be available on www.owens

Record Q2 Earnings: GAAP EPS of $0.87 and Adjusted EPS of $1.06 Revenue Growth of 38% year-over-year Affirms previously announced 2021 and 2022 guidance Owens & Minor, Inc. (NYSE-OMI) today reported financial results for the second quarter of 2021, as summarized in the table below. "We delivered a solid second-quarter, led by outstanding performance in both of our segments. Our results demonstrate the underlying strength of the Global Products segment, and another quarter of improved performance in the Global Solutions segment," said Edward A. Pesicka, President & Chief Executive Officer of Owens & Minor. "Our business blueprint continues to be the framework that helps drive our res

Management will host a conference call to discuss results at 8:30 a.m. EDT on August 3rd Owens & Minor, Inc. (NYSE:OMI) plans to release financial results for the second quarter of 2021 on Tuesday, August 3, 2021, before trading begins on the New York Stock Exchange. Later that same morning, the Company will host a conference call at 8:30 a.m. EDT to discuss the results. Participants may access the call at 866-393-1604. The international dial-in number is 1-224-357-2191. A replay of the call will be available for one week by dialing 855-859-2056. The access code for the conference call, international dial-in and replay is 4479468. A webcast of the event will be available on www.owens-mino